ORGANOGENESIS HOLDINGS INC. Accrued Liabilities, Current
ORGANOGENESIS HOLDINGS INC. (ORGO) had Accrued Liabilities, Current of $49.53 million as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-02-26
- 2025-12-31: Accrued Liabilities, Current $49.53M.
- 2025-09-30: Accrued Liabilities, Current $40.31M.
- 2025-06-30: Accrued Liabilities, Current $26.35M.
- 2025-03-31: Accrued Liabilities, Current $31.14M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2025-12-31 | $49.53M 10-K · filed 2026-02-26 | |
| 2025-09-30 | $40.31M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $26.35M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $31.14M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $39.45M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $36.10M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $38.02M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $39.76M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $30.07M 10-K · filed 2025-02-27 | |
| 2023-09-30 | $34.99M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $27.78M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $28.60M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $26.45M 10-K · filed 2024-02-29 | |
| 2022-09-30 | $34.16M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $36.39M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $32.42M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $37.29M 10-K · filed 2023-03-01 | $36.59M 10-K · filed 2022-03-01 |
| 2021-09-30 | $37.13M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $26.62M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $25.38M 10-Q · filed 2021-05-11 | |
| 2020-12-31 | $23.97M 10-K · filed 2022-03-01 | |
| 2020-09-30 | $26.13M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $24.69M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $21.80M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $23.45M 10-K · filed 2021-03-16 | |
| 2019-09-30 | $20.61M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $20.68M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $20.39M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $20.39M 10-K · filed 2020-03-09 | $25.41M 10-K · filed 2019-03-18 |
| 2018-09-30 | $7.31M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $5.42M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $4.76M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $22.55M 10-K · filed 2019-03-18 | $3.83M 10-K · filed 2018-03-14 |
| 2017-09-30 | $2.70M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $85.83K 10-Q · filed 2017-08-11 | |
| 2017-03-31 | $140.82K 10-Q · filed 2017-05-12 | |
| 2016-12-31 | $50.78K 10-K · filed 2018-03-14 | |
| 2016-09-30 | $14.53K 10-Q · filed 2016-11-18 | |
| 2015-12-31 | $8.47K 10-K · filed 2017-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |